Lonnel Coats, Director at Blueprint Medicines Corp (BPMC), sold 15,800 shares at $81.59 ($1.3M) on 2019-08-15, disclosed to the SEC on 2019-08-19.
Open-market sale of $1.3M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.59 | 4,200 | $343K | 26.3% |
| 2 | $82.48 | 3,098 | $256K | 19.6% |
| 3 | $82.48 | 3,098 | $256K | 19.6% |
| 4 | $83.57 | 2,702 | $226K | 17.3% |
| 5 | $83.57 | 2,702 | $226K | 17.3% |
| Total | $82.62 avg | 15,800 |
| $1.3M |
| 100% |
| Filing → |
| LXRX | BUY | 2023-11-13 | $10K | — | Filing → |
| LXRX | BUY | 2023-06-29 | $22K | — | Filing → |
| LXRX | BUY | 2023-06-26 | $47K | — | Filing → |